SCHEMBL12812469

SCHEMBL12812469

Nc1cccc(CC(=O)Nc2ccc(-c3ccc4ncc(N5CCN(Cc6cccnc6)CC5)nc4c3)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.44
DRD2 P14416 2/20 0.44
RORC P51449 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PORCN Q9H237 1/20 0.41
WNT3A P56704 2/20 0.41
CASP1 P29466 1/20 0.41
CASP4 P49662 1/20 0.41
CASP5 P51878 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 3/20 0.40
EPAS1 Q99814 3/20 0.40
ABCB1 P08183 1/20 0.40
CYP3A4 P08684 1/20 0.40
BCHE P06276 1/20 0.40
WNT1 P04628 1/20 0.39
DYRK1A Q13627 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12812462 0.93 HTR1A (0.47) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL1443280 0.93 DRD2 (0.51) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL27865644 0.92 HTR1A (0.44) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL27865624 0.92 HTR1A (0.47) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL1442810 0.91 HTR1A (0.51) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL10178967 0.91 KCNQ2 (0.46) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL1442923 0.91 DRD2 (0.44) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL12812052 0.91 PSEN1 (0.51) HTR1ADRD2RORCNPC1RAB9A
SCHEMBL12812513 0.91 NPC1 (0.48) HTR1ADRD2NPC1RAB9AWNT3A
SCHEMBL10179675 0.90 HTR1A (0.52) HTR1ADRD2RORCNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 WO disclosed